Cargando…
Neurochemical Biomarkers in patients with COVID-19
The limited data available on CSF analysis in patients with COVID-19 prompted us to conduct a large-scale multicenter study on behalf of the German Society for CSF Diagnostics and Clinical Neurochemistry (DGLN), taking into account a wide range of parameters, including white blood cell count (WCC) i...
Autor principal: | Tumani, Hayrettin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063367/ http://dx.doi.org/10.1016/j.jadr.2023.100573 |
Ejemplares similares
-
Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing
por: Bachhuber, Franziska, et al.
Publicado: (2021) -
Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients
with multiple sclerosis treated with high-efficacy disease-modifying
therapies
por: Petereit, Hela-Felicitas, et al.
Publicado: (2021) -
Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis
por: Edén, Arvid, et al.
Publicado: (2021) -
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
por: Abu-Rumeileh, Samir, et al.
Publicado: (2020) -
Electrochemistry for neurochemical analysis
por: Ross, Ashley E., et al.
Publicado: (2021)